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pts could be divided into two groups according to spirometric values before FESS
(FEV1>70%, mild pulmonary disease, n=7 and FEV1<70%, moderate and severe
pulmonary disease, n=5). One year after FESS, spirometry was unchanged in all
the pts with FEV1>70% with a PEF increase in 2 subjects, while spirometry was
decreased in patients with FEV1<70%, depending on worsening of the pulmonary
status. 1 subject had PEF increase. After FESS the number of hospitalizations in
patients with FEV1>70% was similar to the value observed in the previous year in
the majority of subjects (n=5) or was reduced (n=2) while it was increased in all
the pts with FEV1<70%.
Conclusions: FESS was effective and provided signiﬁcant SND associated symp-
toms relief, with an improvement of the quality of life, despite the possibility of
recurrence. A larger number of pts and a longer follow up period are needed to
evaluate the long term effects of FESS on pulmonary function and to study the
recurrence rate.
P63 CLOSTRIDIUM DIFFICILE (CD) COLITIS IN A CF LUNG
TRANSPLANTED PATIENT
A. Menichella, M. Rolla, P. Troiani, F. Patriarchi, S. Quattrucci. Cystic Fibrosis
Center, Department of Pediatrics, “Sapienza” University of Rome, Italy
CD infection is a rare though often fatal complication after lung transplantation. In
addition, Sirolimus is deemed to increase infections hazard in these patients.
We basely describe the case of one such patient who was cured thanks to timely
diagnosis and appropriate treatment.
A 39-year-old male CF patient underwent Bilateral Sequential Lung Transplantation
in May 2006. In June 2007 Sirolimus was inclosed in the immunosuppressive
regimen for renal failure.
In July 2007, 3 weeks later, the patient presented with diarrhea, high septic fever
(40º) and abdominal pain. Laboratory tests for inﬂammation were markedly in-
creased and abdominal echography revealed thickening of intestinal walls (20mm);
this ﬁnding was conﬁrmed by MR. Massive ascitis was also present.
Because of the history of Sirolimus administration and the clinical patterns a
diagnosis of CD colitis was suspected and the appropriate therapy was instituted.
Sirolimus was discontinued; 5 Toramix aferesis were performed; Metronidazole
(500mg q6h.) and Meropenem (50mg/kg/die) were administered and support
therapy (blood and plasma transfusion, albumin, total parental nutrition) was started.
The patient moderately improved until positive diagnosis of CD infection was
obtained by stool culture. At this point high dose steroids (1mg/kg per day) were
started. The patient progressively improved and inﬂammation indexes normalized
within 10 days. The patient was discharged asymptomatic 3 weeks after admission
and MR demonstrated reduction of bowel thickness from 20mm to 10mm. The
patient has been in excellent health since then.
In conclusion, if clinically compatible, in patients treated with Sirolimus, a diagnosis
of CD should be suspected and timely treated.
P64 LONG TERM FOLLOW-UP OF A CYSTIC FIBROSIS (CF) PATIENT
WITH PREVIOUS NEUROBLASTOMA
R. Casciaro, M. Haupt, S. Pessano, M. Caso, L. Bergamino, L. Minicucci,
R. Lorini. Department of Pediatrics – CF Centre, G. Gaslini Institute, Genova,
Italy
Herein we report the case of L.D.M. a 16-year-old female affected by CF diagnosed
at two months of life by evocative symptoms and conﬁrmed by positive sweat test;
genotype M1V / del-17a, 17b, 18. Stage 3 neuroblastoma of the right adrenal
gland was diagnosed at the age of 22 months. She received antiblastic therapy
for 4 months following AIEOP NB92 protocol, without a signiﬁcant reduction of
the tumour. AIEOP NB92 protocol was followed by surgical therapy and removal
of 70% of the neoplastic mass. The patient was off therapy after four metabolic
radiotherapeutic cycles with MIBG. At 4 years of age she developed iatrogenic
hypothyroidism treated with thyroxin. At 12 years of age hepatic nodular hyperplasia
was demostrated by abdominal US tomography and conﬁrmed by high resolution
CT (HRCT).
The neuroblastoma and the subsequent therapy did not show any side effects on
the pulmonary function of our patient: chronic colonization by oxacillin susceptible
Staphylococcus aureus, only one sputum positive for Pseudomonas Aeruginosa (in
1993 during immunosuppressive therapy). FEV1 70% of predicted values. Moreover
she maintained an optimal nutritional status (BMI 22.89).
From January to May 2007 three episodes of abdominal pain with icterus, hyper-
transaminasemia and hyperbilirubinemia were reported. Abdominal US tomography
showed only microcholelithiasis, while HRCT showed an increased number and
volume of the hepatic lesions. Normal serum and urinary tumor markers level
(NSE, CA19.9, CEA, VMA and HVA).
MIBG scintigraphy showed accumulated metaiodobenzylguanidine in midline epi-
gastric region. PET scintigraphy ruled out an active disease. These results conﬁrmed
the diagnosis of focal nodular hepatic hyperplasia. No variation was found in the
residual retroperitoneal mass volume (84x67x72mm).
We underline this case of a Cystic Fibrosis patient with previous neuroblastoma
because such a long term follow up (14 years) in a neuroblastoma with a stable
retroperitoneal remaining tumour is so uncommon to be reported.
A multidisciplinary approach was necessary in the differential diagnosis of the
hepatic symptoms because of the coexistence of these two complex pathologies.
P65 LUNG EXACERBATION IN A CYSTIC FIBROSIS (CF)
PATIENT CAUSED BY A MULTIRESISTANT EXTENDED
SPECTRUM b-LACTAMASE (ESBL) PRODUCING STRAIN OF
ESCHERICHIA COLI (EC)
M. Caso1, R. Casciaro1, S. Pessano1, L. Ambrosini1, G. Manno2, M. Mentasti2,
P. Morelli2, L. Minicucci1, R. Lorini1. 1Department of Pediatrics – CF Centre;
2General Laboratory of Analysis, G. Gaslini Institute, Genova, Italy
ESBL have the ability to hydrolyse cephalosporins and monobactams, but not
cephamycins or carbapenems. The majority of ESBL-producing organisms have
been reported from hospitalized patients in Intensive Care Units (ICU).
Our experience is about a 47-year-old female pt affected by CF (DF508/DF508),
chronically colonized by mucoid Pseudomonas aeruginosa (PAM) since 1988, in
stable clinical and respiratory conditions (FEV1 40%) until 2005. Her clinical course
was characterized by several lung exacerbations and need for O2 therapy since 2006
and “Non-Invasive Ventilation” since March 2007.
In May 2007, during lung exacerbation treated with iv colistin, amikacin and
ceftazidime, worsening of clinical conditions with severe hypercapnia and acidosis
(pH 7.28; pCO2 88mmHg; HCO−3 35mmol/l) was found and the pt was admitted
in ICU. After one week in ICU, because of clinical improvement (pH 7.368;
pCO2 70.9mmHg; HCO
−
3 39.9mmol/l), the pt was readmitted at the CF center
where started i.v. therapy with ceftazidime, amikacin and ciproﬂoxacin for 3
wks. After a new dramatic worsening of clinical conditions characterized by
fever and dyspnea, a multiresistant ESBL producing strain of EC (106 cfu/ml)
was isolated from sputum. Its antibiotic susceptibility, assessed by disc-diffusion
in Mueller Hinton Agar showed sensibility only to meropenem and fosfomicin
among the 16 tested antibiotics (amikacin, amoxicillin/clavulanate, ampicillin,
aztreonam, cefepime, cefotaxim, cefoxitin, ceftazidime, cefuroxime, ciproﬂoxacin,
fosfomycin, levoﬂoxacin, meropenem, piperacillin/tazobactam, tobramycin and
trimethoprim/sulfametoxazole). ESBL production was conﬁrmed according to CLSI
guidelines. The patient was isolated and changed iv therapy, starting meropenem,
fosfomycin and amikacin, which was performed for 15 days. The patient showed an
immediate clinical improvement and there was a progressive ESBL load reduction
in the sputa, with a simultaneous increase of PAM load to 106 cfu/ml. During
the treatment for EC infection all blood culture taken resulted negative. Although
Enterobacteriaceae are not speciﬁc pathogens in CF, our experience shows that
it’s important to search them in the sputum and to treat. A prompt and speciﬁc
therapy succeeded in eradicating EC ESBL. Collaboration between CF centre and
microbiologists is highlighted!
P66 POSITIVE LUNG I-131 WHOLE SCAN IN A THYROIDECTOMIZED
CYSTIC FIBROSIS PATIENT FOR THYROID CANCER: CYSTIC
FIBROSIS PULMONARY INVOLVEMENT OR THYROID
METASTASIS?
M. Zanardelli, G. Pizzamiglio, M.A. Monti, N. Gervasini, F. Blasi. Adult Cystic
Fibrosis Center, Bronchopneumology Unit, Ospedale Maggiore Policlinico,
Mangiagalli e Regina Elena, Milan, Italy
Cystic ﬁbrosis (CF) is a chronic hereditary disease with increasing life expectancy
(36.5 years) due to the improvement in patient treatment and assistance. As the CF
population is getting older the incidence of degenerative and malignant diseases is
increasing. We describe a case of thyroid cancer in a female CF 47-year-old patient,
who underwent total thyroidectomy and radioiodine ablation with a positive iodine-
131 uptake in the left lung. In this patient the diffuse pulmonary involvement made
the differential diagnosis between primitive CF disease or metastastic illness difﬁ-
cult. The patient, whose CF diagnosis was performed at the age of 32, presented se-
vere pulmonary involvement and chronic Pseudomonas aeuruginosa infection. Dur-
ing the admission to our CF Adult Centre for a high-dose antibiotic therapy because
of pulmonary exacerbation, a nodular lesion at the right thyroid lobe was detected.
The neck US-scan showed features typical for malignancy without lymph nodal
involvement. Fine needle aspiration of the lesion was positive for papillary thyroid
cancer. The patient, after a high-dose antibiotic IV therapy, underwent total thy-
roidectomy and right lymphadenectomy without surgical nor respiratory complica-
tions. The I-131 whole-body scan, performed after radioiodine ablation of post sur-
gical thyroid remnants, showed two areas of focal I-131 uptake in the left lung. Her
serum thyroglobulin (TG) level and antithyroglobulin antibodies below detection
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limits, a known low risk metastasis disease in papillary thyroid cancer, a chest X-ray
unmodiﬁed and the description in the scientiﬁc literature of iodine-131 uptake in
focal bronchiectasis mimicking metastatic thyroid cancer induced to monitor clinical
status without further investigations. Her serum TG remained undetectable at six-
month follow-up and I-131 whole-body at one-year follow-up showed the same lung
focal hot spots. A chest computed tomography scan was performed conﬁrming the
presence of bronchiectasis involving both lung ﬁelds without evidence of pulmonary
metastasis. Aberrant uptake of radioactive iodine is present not only in known in-
ﬂammatory disease of the lung, aspergilloma and respiratory bronchiolitis but false
positive iodine uptake can be present also in case of pulmonary involvement in CF.
P67 SPHENOID SINUS MUCOCELE IN A CYSTIC FIBROSIS CHILD
M. Di Cicco1, F. Ferrario, D. Costantini, C. Colombo. ENT Department –
Pediatrics Department – CF Centre Fondazione IRCCS “Ospedale Maggiore
Policlinico, Mangiagalli e Regina Elena” – University of Milan, Milan, Italy
A six years old male child affected with cystic ﬁbrosis presented to the ENT exam-
ination with a history of nasal obstruction and two episodes of intense headache.
A nasal ﬂexible endoscopy was performed showing a bulging of the all superior wall
of the nasal cavity, an anterior displacement of the medium turbinate’s root and a
reduction of the choana’s size, due to the mass occuping space. The CT scan showed
a homogeneous mass involving entirely the sphenoidal sinus, with an enlargement of
the whole cavity, the posterior portion of the ethmoidal sinuses, the superior and the
middle portion of the nasal cavities, and a partial portion of the choanal lumen. En-
hanced MRI was performed excluding a vascular pattern of the lesion. Thus, the ra-
diological features of these examinations suggested a big sphenoidal mucocele. The
patient was treated with antibiotical prophilaxis i.v. before the surgical treatment.
An endoscopic approach (FESS) in achieving marsupialization and drainage of the
sphenoidal mucocele was carried out. A sharp removal of anterior and inferior
bone walls was performed and a gentle suction of its content of suppurating thick
secretions was actuated.
The mucous within the mucocele cavity was sterile at Gram staining investigation.
The follow up included a clinical evaluation with rinoﬁibroscopy at 1–3–6 months
and an MRI at 6 months.
The marsupialization and drainage of the mucocele is believed to be the mainstay
of treatment and the endoscopic treatment seems to be the most successful tool in
carrying out this type of surgical management, according with the authors’ opinion
that a mini-invasive treatment is the best choice for mucoceles in children and young
adults, where an incision of an external approach can bring to cosmetic distortions.
Moreover this approach results in lower morbidity and complications than external
intranasal or intracranial tecniques; it has a very low rate of recurrence and allows
a good visualisation of the operative ﬁeld with minimal blood loss.
P68 CYSTIC FIBROSIS PATIENT WITH SEVERE RESPIRATORY
FAILURE: RAPID RESOLUTION OF ATELECTASIS WITH NIMV
M.A. Monti, M. Zanardelli, N. Gervasini, G. Pizzamiglio, F. Blasi. Adult Cystic
Fibrosis Center, Bronchopneumology Unit, Ospedale Maggiore Policlinico,
Mangiagalli e Regina Elena, Milan, Italy
Cystic ﬁbrosis (CF) is a hereditary disease with a mild to severe pulmonary
involvement. The most frequent complications are pneumothorax, haemoptysis and
atelectasis. We report a case of one day resolution of atelectasis with the application
of noninvasive mechanical ventilation (NIMV) in a CF patient with bronchopneu-
mopathy, progressive chronic renal failure, malnutrition requiring nutritional support
and toxic multinodular goiter with tracheal compression previously treated with
radioiodine therapy.
A 44-year-old woman with a CF diagnosis at the age of 33, severe pulmonary
disease with an hypoxic hypercapnic respiratory insufﬁciency and chronic Pseu-
domonas aeruginosa infection was admitted to our CF Adult Unit for high-dose
antibiotic therapy because of a febrile pulmonary exacerbation conﬁrmed by an
important worsening of chest x-ray. After four weeks of therapy to overcome the
acute phase, the patient underwent renal biopsy to investigate the chronic renal
failure (amyloidosis associated with chronic disease), before evaluation for lung
transplant waiting list. The investigation was complicated by bladder tenesm and
macro-hematuria with required hemotransfusions and atropine-similar drugs. Due
to the difﬁculty to practice airways clearance techniques the respiratory involvement
worsened and, at the same time, at thorax examination a bronchial breath appeared
in left subclavicular and precordial region. Chest X-ray showed the presence of
“large left hemithorax opacity suggestive for atelectasis”. So we used NIMV for a
longer period of application (the patient was already irregularly performing because
of the discomfort) and with higher level of pressure support to 7 cmH20. The
increase of pressure and an intensive use of NIVM determined a rapid and important
reduction of atelectasis, as shown by the chest X-ray performed the following day,
and an improvement of respiratory exchanges and dyspnoea.
The case conﬁrmed that early, correct and intensive use of NIVM can lead to
atelectasis resolution without the use of invasive approaches.
P69 PULMONARY MALFORMATION AND CYSTIC FIBROSIS
(CF): WHICH DIAGNOSIS, HOW TO TREAT AND TIMING OF
PROCEDURE (CASE REPORT)
R. Padoan1, V. Bennato1, S. De Leone1, G. Battaglia2, R. Maroldi2, D. Falchetti3.
1Cystic Fibrosis Service, AO Spedali Civili, Brescia; 2Department of Radiology,
University of Brescia; 3Paediatric Surgery, AO Spedali Civili, Brescia, Italy
Pulmonary malformations are comprised in the spectrum of CCAM including
bronchial cysts and pulmonary sequestration. They all can complicate with repeated
infections, abscesses, or hemothorax, therefore elective removal is desirable as soon
as possible. In case of sequestration the resolution can be achieved also with simple
embolization of the feeding artery. Concern about diagnosis, timing and modality
of treatment can arise from associated pathology.
Case report: CC, female, born from healthy non-consanguineous parents, had a
prenatal diagnosis of CCAM in the left lung (magnetic resonance at 22 weeks).
Then surgery was scheduled soon after birth. She subsequently received a diagnosis
of CF for neonatal hypertrypsinogenaemia, followed by positive chloride sweat
test (103mEq/l) and extensive molecular analysis of the CFTR gene showing a
compound heterozygosity (R334W/2118del4). A CT scan was performed in the
neonatal period and it revealed a left pulmonary sequestration.
The CF diagnosis induced a more prudential approach and surgery was delayed in
favour of a more conservative treatment as a ﬁrst choice.
At 1 year of age, a CT angiography displayed intralobar pulmonary sequestration,
receiving blood supply from a large vessel originating from descending aorta.
The infant was in good nutritional status, with no respiratory symptoms but
occasional rhinitis. She is on regular chest physiotherapy with PEP-mask, presenting
no bacterial respiratory infection. At 16 months of age, coil embolization of the
abnormal feeding artery was successfully performed, obtaining a 80−90% loss of
vascolarization. At 30 months of age the infant is in good clinical conditions, with
normal growth and no respiratory symptoms.
The case is presented for the rarity of the association of the two pathologies (lung
malformation and CF) and because of the concern in the decision-making process
regarding treatment. Chest surgery in a CF infant should be avoided, if not strictly
needed; thus embolization was considered as the choice treatment in our case.
P70 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN
CYSTIC FIBROSIS
L. Ratclif, A. Nigro, P. Vitullo. U.O.S. Cystic Fibrosis – Cerignola (FG), Italy
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is an increasing
problem in both the general population and cystic ﬁbrosis (CF) patients. MRSA is
recognized s a bacterial pathogen in CF patients, although its clinical effects can be
variable. The isolation of MRSA in the sputum of patients with CF had questionable
signiﬁcance; in many instances, it was considered to be related to colonization rather
than being directly related to deterioration in the course of pulmonary disease.
Aim: To determine determine whether MRSA infection has a deleterious effect on
the clinical status of patients with CF.
Methods: Patients with MRSA in respiratory cultures during a three year period,
September 2004-September 2007, were identiﬁed and compared with controls
matched for age, sex, and respiratory function. Respiratory function tests, anthro-
pometric data, symptoms and clinical signs, chest x-ray score were considered in
the evaluation of the two groups.
Results: From a clinic population of 86, 32 CF patients (22 boys, 10 girls, median
age 14 years) had positive sputum or cough swab cultures for MRSA. Thirty-three
age-sex-matched MRSA-negative controls were identiﬁed. Only 2 of 32 (6.3%)
MRSA-positive patients showed chronic colonization. In 30 of 32 (93.7%) patients
who were not receiving speciﬁc antibiotic therapy MRSA has been eradicated. Prior
to initial isolation 27/30 (90%) MRSA-positive CF patients received more antibiotic
treatments (oral quinolones in 70% of cases, oral cotrimoxazolo in 51%, intravenous
aminoglycosides in 37%, oral quinolones associated with nebulized tobramicin in
7%, oral/intravenous cephalosporins in 6% of children). Three of 30 (10%) MRSA-
positive patients were treated with no antibiotic therapies before MRSA acquisition.
There were no signiﬁcant differences between the two groups with respect to change
in weight, body mass index, decline in chest x-ray appearance, pulmonary function.
Conclusion: MRSA infection in children with CF does not signiﬁcantly affect
respiratory function; acquisition did not appear to directly affect the course of the
pulmonary disease in these patients, even though no patient received any treatment
for their MRSA. MRSA decolonization can be successful in a high proportion of CF
patients also without use of speciﬁc antibiotic protocols. Although more studies are
needed to evaluate the full signiﬁcance of MRSA colonization among patients with
CF, a judicious use of antibiotics and a segregation of in and out patients should
